TRACON Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of products for oncology and ophthalmology treatment, and Micromet, Inc., , a biopharmaceutical company focused on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, announced today that TRACON has started the treatment of the first cancer patient in …
More: continued here